[Retracted] Serum Markers CA125, CA153, and CEA along with Inflammatory Cytokines in the Early Detection of Lung Cancer in High‐Risk Populations

Guangping Li, Hongxin Zhang, Lei Zhang, Huaqun Liu, Songlin Li, Yanan Wang, Xiaoyun Deng

Open source

DOI
10.1155/2022/1394042
Published
2022-01
Container
BioMed Research International
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/1394042,
  title = {[Retracted] Serum Markers CA125, CA153, and CEA along with Inflammatory Cytokines in the Early Detection of Lung Cancer in High‐Risk Populations},
  author = {Guangping Li and Hongxin Zhang and Lei Zhang and Huaqun Liu and Songlin Li and Yanan Wang and Xiaoyun Deng},
  year = {2022},
  journal = {BioMed Research International},
  doi = {10.1155/2022/1394042},
  url = {https://doi.org/10.1155/2022/1394042}
}

RIS

TY  - JOUR
TI  - [Retracted] Serum Markers CA125, CA153, and CEA along with Inflammatory Cytokines in the Early Detection of Lung Cancer in High‐Risk Populations
AU  - Guangping Li
AU  - Hongxin Zhang
AU  - Lei Zhang
AU  - Huaqun Liu
AU  - Songlin Li
AU  - Yanan Wang
AU  - Xiaoyun Deng
PY  - 2022
JO  - BioMed Research International
DO  - 10.1155/2022/1394042
UR  - https://doi.org/10.1155/2022/1394042
ER  - 

APA

Li, G., Zhang, H., Zhang, L., Liu, H., Li, S., Wang, Y., & Deng, X. (2022). [Retracted] Serum Markers CA125, CA153, and CEA along with Inflammatory Cytokines in the Early Detection of Lung Cancer in High‐Risk Populations. BioMed Research International. https://doi.org/10.1155/2022/1394042

Source records